<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">606178376</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20210128100756.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">210128e20150901xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s11136-015-0943-5</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s11136-015-0943-5</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[M. Chahua, A. Sánchez-Niubò, M. Torrens, L. Sordo, M. Bravo, M. Brugal, A. Domingo-Salvany]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Purpose: Drug addiction and psychiatric disorders are frequently concomitant; however, few studies have investigated the impact of psychiatric disorders other than substance use disorder (SUD) on health-related quality of life (HRQoL) in drug users not in treatment. We studied the association of psychiatric disorders other than SUD with HRQoL in a street-recruited sample of cocaine and/or heroin users. Methods: It is a cross-sectional study involving 287 young users of cocaine and/or heroin in Barcelona, Spain. HRQoL was assessed with the Nottingham health profile (NHP). Patterns of drug use and mental disorders were assessed using the Spanish version of the psychiatric research interview for substance and mental disorders IV, and degree of dependence through the severity of dependence scale (SDS). The association of mental disorders with HRQoL was assessed through a Tobit regression analysis. Results: The overall NHP score was 23.9 (SD=20.5, range 0-91.7). Sixty-one percent of the sample had two or more SUDs; 22% had at least one non-SUD Axis I disorder (anxiety, mood, psychotic, or eating disorder); and 27.2% had a borderline personality disorder (BPD) and/or antisocial personality disorder. Variables negatively associated with the global NHP score were psychosis [transformed beta coefficient: 15.23; 95% confidence interval [CI] 4.48-25.97], BPD (9.55; 95% CI 2.95-16.15), severity of dependence (8.12; 95% CI 3.37-12.87), having two or more SUDs (for two or three SUDs: 6.83; 95% CI 2.08-11.59) (&gt;3 SUDs: 7.70; 95% CI 1.72-13.68) and the intravenous use of some substance (10.20; 95% CI 6.00-14.40). Conclusion: HRQoL among street-recruited illegal substance users was impaired, particularly among those with psychiatric comorbidity, psychosis, and BPD being especially relevant.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer International Publishing Switzerland, 2015</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Quality of life</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Borderline personality disorder</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Psychotic disorders</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Substance use disorder</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Illicit drug users</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">PRISM</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Chahua</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sánchez-Niubò</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Drug Abuse Epidemiology Research Group, IMIM-Hospital del Mar, Dr Aiguader 88, 08002, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Torrens</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Addiction Research Group, IMIM-Hospital del Mar, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Sordo</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bravo</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Brugal</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Agència de Salut Pública de Barcelona, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Domingo-Salvany</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Drug Abuse Epidemiology Research Group, IMIM-Hospital del Mar, Dr Aiguader 88, 08002, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">24/9(2015-09-01), 2129-2137</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">24:9&lt;2129</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">24</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s11136-015-0943-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s11136-015-0943-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Chahua</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Escuela Nacional de Sanidad, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sánchez-Niubò</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Drug Abuse Epidemiology Research Group, IMIM-Hospital del Mar, Dr Aiguader 88, 08002, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Torrens</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Addiction Research Group, IMIM-Hospital del Mar, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Sordo</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bravo</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Brugal</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Agència de Salut Pública de Barcelona, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Domingo-Salvany</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">Drug Abuse Epidemiology Research Group, IMIM-Hospital del Mar, Dr Aiguader 88, 08002, Barcelona, Spain</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Springer International Publishing</subfield>
   <subfield code="g">24/9(2015-09-01), 2129-2137</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">24:9&lt;2129</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">24</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
 </record>
</collection>
